Using Feasibility to Guide Indication Selection for Your Proof-of-Concept Clinical Trial
The following blog outlines strategic decisions to consider at the feasibility stage of a proof-of-concept study.
Read More
Phase I Clinical Trials: Why Strong Pharmacy Support of Early Phase Protocols Matters – Part 2
Following part 1 of our series, this post provides valuable insights into the role of manufacturing and compounding, investigational drug blinding, dispensing, dosing, and the four areas where pharmacy procedure adherence is crucial to successful early phase clinical trial execution.
Read More
Phase I Clinical Trials: Why Strong Pharmacy Support of Early Phase Protocols Matters – Part 1
The following blog discusses suggestions for integrating CPU pharmacy staff with Phase I clinical trial teams for streamlined processes and accelerated timelines.
Read More
COVID-19 Clinical Trials: 6 Operational Considerations You Should Evaluate
The following blog is a high-level overview of special considerations specific to clinical trials addressing COVID-19.
Read More
A 505(b)(2) Primer: Building the Bridge Between an Approved Drug and Your Novel Therapy
This blog features considerations and recommendations for sponsors exploring a 505(b)(2) pathway to drug approval. It was co-written by the Editors at Uncommon Conversations and the experts at Camargo.
Read More
Developing new scientists to meet increasing industry demand
The following blog highlights recent news surrounding Worldwide’s additions to its fellowship program and discusses the importance of preparing scientists and researchers to support tomorrow’s clinical trial needs.
Read More
